What Is Dapagliflozin Used For in Type 2 Diabetes?

Type 2 diabetes is a chronic condition characterized by elevated blood sugar levels and insulin resistance. Managing blood sugar is essential to prevent complications like heart disease, kidney damage, and nerve problems. One treatment option your doctor may prescribe is dapagliflozin. Below, we explain what dapagliflozin is, how it works, when and why it’s used, and what you need to know about safety and side effects.

How Dapagliflozin Works

Dapagliflozin belongs to a class of medications called sodium-glucose co-transporter-2 (SGLT2) inhibitors. Its primary action takes place in the kidneys:

• Dapagliflozin blocks SGLT2 proteins in the kidney’s proximal tubules.
• This reduces reabsorption of glucose back into the bloodstream.
• Extra sugar (glucose) is excreted through urine, lowering blood glucose levels.

By using this mechanism, dapagliflozin helps bring blood sugar into a healthier range, complementing diet and exercise.

Indications: When and Why It’s Prescribed

Dapagliflozin can be used on its own or alongside other diabetes medications. Common scenarios include:

• Adults with type 2 diabetes not adequately controlled by diet, exercise, and metformin.
• Patients needing additional blood sugar lowering despite other oral agents or insulin.
• People with established cardiovascular disease (CVD) to reduce the risk of heart-related events.
• Individuals with chronic kidney disease (CKD) to slow kidney function decline.

Your healthcare provider will assess your individual needs—blood sugar levels, kidney function, heart history—and determine if dapagliflozin is right for you.

Key Benefits Beyond Blood Sugar Control

While lowering blood sugar is the main goal, dapagliflozin offers extra advantages that may influence your doctor’s decision:

• Cardiovascular Protection
  • Shown to reduce the risk of hospitalization for heart failure in people with or without preexisting heart disease.
  • May lower the chance of major adverse cardiovascular events (heart attack, stroke) in those with established CVD.

• Kidney Health
  • Slows progression of diabetic kidney disease in patients with albuminuria (protein in urine).
  • Helps preserve estimated glomerular filtration rate (eGFR) longer than some other therapies.

• Weight Management
  • Modest weight loss (1–3 kg) over several months, due to glucose excretion and mild fluid loss.
  • Can support overall lifestyle changes centered on healthy eating and activity.

• Blood Pressure Reduction
  • Mild decrease in systolic BP (about 2–5 mm Hg), helpful if you also have high blood pressure.

Typical Dosage and Administration

• Starting dose: 5 mg taken once daily in the morning, with or without food.
• Maintenance dose: May increase to 10 mg once daily if additional blood sugar lowering is needed and tolerated.
• No dose adjustment generally required based on meals or time of day, though morning dosing can minimize nighttime urination.

Always follow your doctor’s specific instructions. Do not change your dose or stop taking dapagliflozin without medical guidance.

Common Side Effects

Most people tolerate dapagliflozin well, but some side effects can occur:

• Genital yeast infections (men and women)
• Urinary tract infections (UTIs)
• Increased urination or urinary frequency
• Mild dehydration (dizziness or lightheadedness)
• Thirst

These effects result from extra glucose and water being passed in the urine. Drinking plenty of water and practicing good hygiene can help reduce risks.

Serious Risks and Precautions

While rare, certain complications require immediate attention:

• Diabetic ketoacidosis (DKA)
  • Can occur even with normal or mildly elevated blood sugar.
  • Symptoms: nausea, vomiting, abdominal pain, rapid breathing, confusion.
• Volume depletion and low blood pressure
  • Risk higher in older adults, those on diuretics, or with kidney impairment.
• Acute kidney injury
  • More likely if you become dehydrated (vomiting, severe diarrhea).
• Fournier’s gangrene (necrotizing fasciitis of the genital area)
  • Extremely rare but life-threatening.
• Hypersensitivity reactions
  • Rash, itching, swelling—stop medication and seek help if these occur.

Before starting dapagliflozin, your doctor will check your kidney function (eGFR). It’s generally not recommended if eGFR is below 25–30 mL/min/1.73 m² or for patients on dialysis.

Who Should Avoid Dapagliflozin?

Dapagliflozin may not be suitable for everyone:

• Type 1 diabetes (off-label use increases DKA risk)
• History of serious urinary or genital infections
• Severe liver disease (hepatic impairment)
• Pregnancy or breastfeeding
• Low blood pressure or conditions causing volume depletion
• Known hypersensitivity to dapagliflozin or ingredients

Always discuss your full medical history, including other medications, supplements, and health conditions, with your healthcare provider.

Monitoring and Follow-Up

Regular follow-up is essential to ensure safety and effectiveness:

• Kidney function tests (eGFR) every 6–12 months
• Blood pressure checks
• Regular blood sugar/HbA1c monitoring
• Awareness of early symptoms of dehydration, infection, or DKA

Prompt reporting of any concerning signs—such as persistent nausea, rapid breathing, or swelling—is crucial.

What to Do If You Have Symptoms

If you’re experiencing new or worsening symptoms—whether you’re on dapagliflozin or not—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need to seek medical care now or schedule a doctor’s appointment.

Speak to a Doctor

Dapagliflozin can be an effective tool in managing type 2 diabetes, improving cardiovascular and kidney outcomes, and supporting healthy weight and blood pressure. However, only a healthcare professional can determine if it’s the right choice for you. Speak to a doctor about any life-threatening or serious concerns—don’t delay seeking help if you experience severe side effects or symptoms.